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b-Adrenergic Regulation
of Synaptic NMDA Receptors
by cAMP-Dependent Protein Kinase
Indira M. Raman, Gang Tong,* and Craig E. Jahr Ca21-dependent phosphatase calcineurin (Lieberman
and Mody, 1994; Tong and Jahr, 1994). As shown byVollum Institute
Tong et al. (1995) in cultured hippocampal neurons, acti-Oregon Health Sciences University
vation of calcineurin also occurs during synaptic stimu-Portland, Oregon 97201
lation, thereby diminishing the amplitude of subsequent
NMDA receptor±mediated excitatory postsynaptic cur-
rents (EPSCs). Thus, the flux through NMDA receptorsSummary
during synaptic activity provides negative feedback that
limits the rise in intracellular Ca21.To identify the protein kinases regulating synaptic
The present experiments investigated the possibilityNMDA receptors, as well as the conditions favoring
that the autoregulation of NMDA receptor conductanceenhancement of NMDA receptor±mediated excitatory
might itself be subject to modulation; i.e., given that thepostsynaptic currents (EPSCs)by phosphorylation, we
decrement in NMDA EPSCs is phosphatase dependent,studiedthe effects of kinase activation and inhibition in
conditions that elevate the activity of particular kinases,hippocampal neurons. Inhibition of cAMP-dependent
such as the stimulation of second messenger±coupledprotein kinase (PKA) prevented recovery of NMDA re-
receptors, might shift an equilibrium toward phosphory-ceptors from calcineurin-mediated dephosphorylation
lation of NMDA receptors or associated proteins. Suchinduced by synaptic activity, suggesting that tonically
a change might enable more Ca21 to flow through theactive PKA phosphorylates receptors during quies-
channels during periods of high synaptic activity.cent periods. Conversely, elevation of PKA activity by
Initial experiments were directed toward identificationforskolin, cAMP analogs, or the b-adrenergic receptor
of the kinase or kinases that might complement theagonists norepinephrine and isoproterenol overcame
role of calcineurin in regulating NMDA receptors. Sincethe ability of calcineurin to depress the amplitude of
calcineurin and cAMP-dependent protein kinase (PKA)NMDA EPSCs. Thus, stimulation of b-adrenergic re-
are colocalized at synaptic densities by anchoring pro-ceptors during excitatory synaptic transmission can
teins (Coghlan et al., 1995), PKA is a likely candidate forincrease charge transfer and Ca21 influx through
modulation of synaptic receptors, as shown for hippo-NMDA receptors.
campal a-amino-3-hydroxy-5-methyl-4-isoxazolepropi-
onate (AMPA)/kainate receptors (Liman et al., 1989;
Greengard et al., 1991; Wang et al., 1991; Rosenmund
Introduction et al., 1995). The present experiments provide evidence
that, in the absence of synaptic activity, NMDA recep-
N-methyl-D-aspartate (NMDA) receptors are implicated tors are phosphorylated by basally active PKA, thus
in a variety of synaptic and cellular changes, including enhancing NMDA EPSCs after periods of relative quies-
development, plasticity, and excitotoxicity. These pro- cence. During excitatory transmission, Ca21 influx stim-
cesses are shaped by the rise in intracellular Ca21 re- ulates calcineurin, leading to a reduction of NMDA
sulting from Ca21 influx through NMDA receptors (e.g., receptor currents. However, b-adrenergic receptor stim-
Choi and Rothman, 1990; Perkel et al., 1993; Linden, ulation by theneurotransmitter norepinephrinecan over-
1994; Scheetz and Constantine-Paton, 1994). Conse- come the ability of calcineurin to limit Ca21 entry during
quently, augmentation or diminution of currents through synaptic activity. Thus, when excitatory synaptic trans-
NMDA receptors is likely to influence these intracellular mission coincides with norepinephrine release, hippo-
events. NMDA receptors seem particularly susceptible campal neurons may be able to sustain a larger NMDA
to modulation, as they contain multiple consensus sites receptor±mediated Ca21 influx.
for phosphorylation by several protein kinases (Holl-
mann and Heinemann, 1994). Protein kinase C (PKC) Results
and tyrosine kinases have been shown to phosphorylate
NMDA receptor subunits directly (Tingley et al., 1993; Figure 1A illustrates the protocol used inall experiments.
Moon et al., 1994; Lau and Huganir, 1995). Moreover, As in Tong et al. (1995), T2, the test EPSC following a
kinase activation or phosphatase inhibition can increase train of four conditioning EPSCs was compared to T1,
NMDA receptor±mediated currents measured in mem- the test EPSC following a train of conditioning stimuli
brane patches and whole cells (Chen and Huang, 1991, given while the synapse was bathed in the NMDA recep-
1992; Lieberman and Mody, 1994; Tong and Jahr, 1994; tor antagonist D-2-amino-5-phosphonopentanoic acid
Wang et al., 1994; Wang and Salter, 1994). (D-AP5). D-AP5 was applied for only 200 ms and was
NMDA receptor±mediated Ca21 flux also triggers pro- completely washed away before the test EPSC (T1) was
cesses that reduce currents through NMDA receptors elicited (see Experimental Procedures). The ratio of the
(Vyklicky et al., 1990; Legendre et al., 1993), such as test EPSC amplitudes, T2/T1 (test EPSC ratio), was
Ca21-dependent depolymerization of actin filaments 0.77 6 0.10 (mean 6 SD; n 5 39). Because transmitter
(Rosenmund and Westbrook, 1993) and activation of the release is unaltered by D-AP5 (Tong et al., 1995), differ-
ences in theamplitudes of T1 and T2 reflect autoregula-
tion of postsynaptic NMDA receptor sensitivity to re-*Present address: Department of Pharmacology, University of Cali-
fornia, San Francisco, California 94143. leased transmitter.
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Figure 1. Activity-Dependent Regulation of NMDA EPSCs
(A) Responses of a cell to the stimulation protocol described in
Experimental Procedures. Traces are averages of 13 (T1) and 14
(T2) episodes. Test EPSCs with and without D-AP5 application
during the conditioning pulses are indicated by T1 and T2, respec-
tively. C1 indicates the first conditioning EPSC. In all figures, the
bar indicates the duration of application of 100 mM D-AP5 for the
response represented by the thick trace.
(B) Cycling of test EPSC amplitudes for 4 cells during continuous
pipette perfusion with K±gluconate. Amplitudes of C1, T2, and T1
in each cell were normalized to the mean C1 amplitude from epi-
sodes 2±5. Horizontal bars above the data indicate episodes for
which D-AP5 was applied for 200 ms during the conditioning pulses
(hence no triangles). Vertical bars are standard errors and are only
included on the first T2 and T1 of each series for clarity. The
increasing amplitudes of the error bars reflect the variable run-up
Figure 2. PKA Inhibition Prevents Recovery of Test EPSCsor run-down in the different cells; in all cases, the cycling of test
EPSC amplitudes was evident, superimposed on the increasing or (A) Including 1 mM PKI in the patch pipette abolished the difference
declining responses. in amplitude between T2 and T1. Traces have been averaged.
(B) The peak amplitudes of C1, T1, and T2 for each episode are
plotted against time after onset of recording for the cell represented
Figure 1B illustrates that at least 2 episodes (each in (A). Gaps in the plot of T2 and T1 are due to verification of D-
composed of conditioning and test stimuli) were re- AP5 washout as described in Experimental Procedures.
(C) Plot of C1, T2, and T1 against time during pipette perfusion.quired for the increase in T1 or decrease in T2 to reach
The recording pipette was initially perfused with controlK±gluconatea plateau. Possible reasons for the delay are discussed
solution. At 7.5 min, the intracellular flow was switched to K±in Figure 5. Because of this ªcycling,º the mean ampli-
gluconate with 1 mM PKI.
tudes of T1 and T2 in all experiments were obtained
by averaging all but the first in a series of 5 episodes
(either with or without D-AP5) so that the maximal differ- the absence of strong synaptic activity. Presynaptic
mechanisms are not likely to be involved, since testence between T1 and T2 could be measured. In each
series of episodes, the mean T1 is significantly larger EPSCs mediated by AMPA receptors were not affected
by preceding NMDA receptor±mediated EPSCs (Tongthan the mean T2 in the preceding or following series
of episodes (p , .025, unpaired t test, one-tailed), indi- et al., 1995).
To assess whether this phosphorylation is mediatedcating that cycling of test EPSC amplitude persists for
at least 20 min during pipette perfusion. by PKA, the experiment was performed with PKA inhibi-
tory peptide 5±24 (PKI) at 1 mM (n 5 4) or 100 nM (n 5The reduction in T2 is triggered by the influx of Ca21
through NMDA receptors, which activates calcineurin 7) included in the patch pipette. Under these conditions,
the test EPSC ratio was brought to 1.00 6 0.06 (pooledand shifts an equilibrium toward dephosphorylation of
receptors or associated proteins. Conversely, the incre- data), as illustrated in Figure 2A and summarized in
Figure 4B. Although the effect of another putative PKAment in T1 probably arises from rephosphorylation in
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blocker (Rp cAMPS; 100 mM) was examined, the results
were too variable to be interpreted (n 5 9; see Figure
4B). Figure 2B shows the time course of the effect of
1 mM PKI on the responses of the cell in Figure 2A.
Stimulation began 2 min after obtaining the whole-cell
configuration. Initially, the amplitudes of the first condi-
tioning EPSC (C1) and T2 were relatively high, and both
decreased substantially in the first 1.25 min of recording.
With successive episodes, the T1 amplitudes showed
no incrementation, and the subsequent T2 amplitudes
showed no diminution. This pattern was observed in all
PKI-containing cells, indicating that blockade of PKA
prevented the rephosphorylation of NMDA receptors.
To ascertain that PKI could eliminate cycling, 1 mM PKI
was perfused into the patch pipette during recording.
As the peptide was dialyzed into the cell, the cycling
was reduced and then abolished, as shown in Figure
2C. While this cell exhibited moderate run-up initially,
the final amplitudes of C1 and of the test EPSCs appear
equivalent to the ªdephosphorylatedº amplitudes of C1
and T2, respectively, just prior to PKI perfusion (at about
7 min).
The robust effect of PKI, even at concentrations as
low as 100 nM, suggests that other endogenous kinases
such as PKC, Ca21/calmodulin-dependent protein ki-
nase, or cGMP-dependent protein kinase (PKG) were
unable, under these conditions, to reverse the effect of
calcineurin. In fact, the difference between T2 and T1
persisted for at least 9 min when 10 mM PKC inhibitory
peptide (PKC-I) was included in the pipette (n 5 6; see
Figure 4B). In 3 cells, 9±20 min after stimulation began,
the difference decreased or disappeared; the other 3
Figure 3. b-Adrenergic Agonists Overcome the Reduction of the
cells continued to cycle for the length of the recording Test EPSC by Calcineurin
(5±15 min). Given the rapidity and efficacy of intracellular
(A) Averaged records from a single cell, before (top) and after (bot-
PKI, it is unlikely that the slow, sporadic effect of PKC-I tom) application of 10 mM norepinephrine. Scale bars apply to both
on the test EPSC ratio can be wholly ascribed to insuffi- sets of traces.
(B) Summary of effects of noradrenergic agonists and antagonistscient dialysis. PKC inhibition therefore does not appear
on the test EPSC ratio. Bars indicate SD; asterisks indicate that theto block strongly the cycle of phosphorylation and de-
test EPSC is increased significantly (p , .01, Dunnett's test forphosphorylation.
multiple comparisons with a control; Dunnett, 1964) above controls.
While basal levels of PKA are sufficient to rephosphor- The dotted line at a ratio of 1 is drawn to facilitate comparison.
ylate the receptors when synaptic activity is low, physio- isoprot, isoproterenol; norepi, norepinephrine; pro, propranolol.
logical stimulation of PKA activity may shift the balance
between phosphorylation and dephosphorylation to-
presence of kinase inhibitors. Figure 3B shows that theward the former. Several neurotransmitters that are re-
b-adrenergic receptor agonist isoproterenol (1 mM) alsoleased in the hippocampus activate adenylyl cyclase.
raised the test EPSC ratio to 0.97 6 0.05 (n 5 6; p , .01),For example, the locus coeruleus sends a noradrenergic
while the b-adrenergic receptor antagonist propranololprojection to the hippocampus, and norepinephrine act-
(300 nM) blocked the effect of 1 mM norepinephrine oning at b-adrenergic receptors can raise intracellular PKA
the test EPSC ratio (0.76 6 0.10; n 5 4). The a2-adrener-activity (e.g., Madison and Nicoll, 1986a, 1986b; Pedar-
gic agonist UK14304 (1 mM), which is negatively coupledzini and Storm, 1993). To investigate whether b-adrener-
to PKA, did not significantly affect the test EPSC ratiogic stimulation can overcome the effect of calcineurin
(0.75 6 0.095; n 5 3). None of the noradrenergic agonistsactivation, the test EPSC ratio was examined in the pres-
produced a detectable change in holding current, andence of norepinephrine. As illustrated inFigure 3A, appli-
only 1 of the 12cells exposed to UK14304or norepineph-cation of 1±10 mM norepinephrine brought the test EPSC
rine showed evidence of presynaptic inhibition.ratio to 0.98 6 0.06 (n 5 8), significantly greater than
Presumably, norepinephrine raised the test EPSC ra-the control ratio (p , .01, Dunnett's test for multiple
tio to about 1 by increasing the proportion of phosphory-comparisons with a control; Dunnett, 1964). In this cell,
lated receptors, via elevation of PKA activity. If so, acti-the amplitudeof C1 also increased, as did the ratio of the
vators of PKA should also be sufficient to abolish thefirst two EPSCs, C1/C2. While this apparent potentiation
difference between T2 and T1. The experiment wasmay have resulted from a presynaptic effect of PKA
therefore repeated in the presence of various kinase(e.g., Chavez-Noriega and Stevens, 1994), such run-up
activators, and the resulting test EPSC ratios are dis-was inconsistent across cells and was also seen occa-
sionally in control solutions (see Figure 2C) or in the played in Figure 4B, along with the data from kinase
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Figure 5. The Rate of Phosphorylation and Dephosphorylation De-
pends on Intracellular Buffering Capacity
(A) Plots of C1, T2, and T1 against time after onset of recording
for 5 cells buffered with 0.5 mM EGTA. Peak currents were normal-
ized as in Figure 1B. Bars indicate SEM. Asterisks indicate that the
first T1 is significantly larger that the final T2 (p , .005, paired
t-test, one-tailed).
(B) Plot as in (A), but cells were buffered with 10 mM EGTA (n 5 9).
In this case, T1 is not at first significantly larger than T2 (p 5 .1)
but increases gradually.
and Sp cBIMPS (100 mM; 0.99 6 0.02; n 5 5). Figure 4A
shows the responses of a cell before (top) and after
(bottom) application of Sp cBIMPS. In 5 of 6 cells, 40 mM
dideoxyforskolin, which should control for nonspecific
effects of forskolin, had no significant effect (test EPSCFigure 4. Manipulations That Elevate or Block PKA Can Change the
Test EPSC Ratio ratio of 0.82 6 0.12); in the sixth cell, the test EPSC
ratio was 1.07. These data are consistent with a PKA-(A) Averaged records from a single cell before (top) and after (bot-
tom) application of the cAMP analog Sp cBIMPS (100 mM). Scale mediated effect of norepinephrine on the test EPSC
bars apply to both sets of traces. ratio.
(B) Summary of effects of kinase activators and inhibitors on the Figure 4C quantifies the effect of the noradrenergic
test EPSC. Error bars, asterisks, and dotted line are as in Figure
agonists and cAMP analogs, showing the percentage3. Abbreviations as given in text; ddFSK, dideoxyforskolin; FSK,
change in the test EPSC ratio from within-cell controls.forskolin. The PKC-I ratio was constructed from measurements
The percentage change by norepinephrine, isoprotere-made during the first 9 min of recording (see text).
nol, Sp cAMPS, and Sp cBIMPS was significant (p ,(C) The percentage change from the test EPSC ratio in within-cell
controls. Asterisks indicate significant differences (p , .0025, paired .0025, paired t test, one-tailed) and comparable, while
t-test, one-tailed). Abbreviations as in text and Figure 3; concentra- UK14304 had no significant effect (p 5 .4).
tions are given in the text, and norepinephrine data were obtained Previous work (Tong et al., 1995) associated the re-
only with 10 mM (n 5 5).
duction of T2 with respect to T1 with desensitization
of the receptor. However, the present experiments sug-
gest a decoupling of dephosphorylation and desensiti-inhibitors. Extracellularly applied activators of PKA all
abolished or significantly reduced the difference be- zation. The earlier experiments used 0.5 mM EGTA to
buffer intracellular Ca21. Under this condition, as illus-tween T2 and T1 (p , .01; Dunnett, 1964). These in-
cluded forskolin (40 mM; 1.03 6 0.09; n 5 5) and the trated in Figure 5A, C1 and T2 were fairly constant in
amplitude over sequential episodes of stimulation. T2cAMP analogs Sp cAMPS (100 mM; 1.00 6 0.07; n 5 4)
b-Adrenergic Regulation of Synaptic NMDA Receptors
419
stayed relatively small throughout the series of epi- adenylyl cyclase (norepinephrine and isoproterenol) can
sodes, consistent with activity-dependent dephosphor- overcome cycling. Thus, PKA can antagonize the effects
ylation or desensitization that took place within the of calcineurin. Calcineurin and PKA may oppose one
1.5 s between C1±C4 and T2. The first T1 was signifi- another not only by competing for the same site(s) of
cantly larger (p , .005, paired t test, one tailed; n 5 phosphorylation but also by regulating one another. For
5) than the T2 immediately before it, consistent with instance, calcineurin can reduce PKA activity by depho-
phosphorylation and resensitization of receptors during sphorylating, and thereby stimulating, at least two types
the 15 s interval between episodes. of phosphodiesterases (Sharma and Wang, 1985, 1986).
In contrast, the present experiments used 10 mM
EGTA intracellularly. Although the test EPSC ratios un-
der these different buffer conditions were indistinguish- Physiological Control and Effect of Po Cycling
able, with high EGTA, activity-dependent diminution of The signal for decreasing the Po of NMDA receptors via
T2 occurred over a longer period of time (30±45 s) than calcineurin stimulation appears to be synaptic activity
in low EGTA (,1.5 s), as shown in Figure 5B (also see (Tong et al., 1995). While tonic levels of PKA apparently
Figure 1B). Because of faster buffering, the intracellular rephosphorylate receptors when calcineurin is inactive,
concentration of free Ca21 presumably rises more slowly phosphorylation can be raised above basal levels by
in the high EGTA condition, and more stimulation is norepinephrine. Thus, NMDA receptors are subject to a
required to achieve Ca21 concentrations adequate for complex system of regulation by calcineurin and PKA,
activation of calcineurin. Dephosphorylation is therefore which provides negative feedback during activity,
slowed, but nevertheless diminishes the amplitude of primes for a large response after inactivity, and can
the NMDA EPSCs. However, the slowed decrease in the maintain receptors in a higher Po state when, for exam-
NMDA EPSC amplitude suggests that the decrease is ple, norepinephrine shifts the equilibrium toward phos-
not desensitization dependent. This idea is supported phorylation. In vivo, several variables may influence the
by the result that, with successive episodes, the ampli- level of phosphorylation of NMDA receptors, including
tude of the conditioning EPSCs, represented again by the time course and magnitude of Ca21 influx, the prox-
C1, decreased in parallel with the amplitude of T2. The imity of Ca21 influx and effector enzymes, the affinity
parallel decrement in the amplitudes of C1 and T2 indi- and kinetics of endogenous Ca21 buffers, as well as
cates that the amplitude of T2 is not an immediate the concentration, location, and efficiency of PKA and
consequence of the conditioning EPSCs. Rather, de- calcineurin. The buffering capacity of the cell can control
phosphorylation may decrease EPSC amplitudes by fa-
the rate at which the NMDA receptors change state
voring a state of the NMDA receptors with a lower maxi-
after synaptic activity. Experimentally, in low buffering
mal open probability (Po), but probably not a lower conditions (0.5 mM EGTA), dephosphorylation can oc-
single-channel conductance (see Lieberman and Mody,
cur within 1.5 s, but with higher buffering (10 mM EGTA),1994). The gradual (30±45 s) increase in the amplitude
the time course of dephosphorylation is prolonged atof T1 may result from phosphorylation back to a higher
least 10-fold, possibly owing to a slower rise in free Ca21Po state. As further evidence against desensitization as and consequent slower activation of calcineurin. Fasta mechanism of the cycling, the 15 s interval following
buffering with BAPTA prevents dephosphorylation alto-the final D-AP5-free episode should be sufficient for
gether (Tong et al., 1995). However, as long as bufferingresensitization, even in the high EGTA condition (Sather
is relatively slow (e.g., EGTA as opposed to BAPTA), theet al., 1992; Lester and Jahr, 1992). Instead, T1 was not
extent of the effect is the same. The change inat first statistically different from the preceding T2
the amplitude of NMDA EPSCs may influence firing(p 5 .10; n 5 9), but then increased in amplitude over
frequency (see Lanthorn et al., 1984); perhaps more2±3 successive episodes to reach a level significantly
importantly, variations in NMDA receptor±mediatedlarger than that of T2. Finally, in the experiments using
current may have marked intracellular effects as a con-PKI, the dephosphorylated receptors should still desen-
sequence of modulation of Ca21-dependent processes.sitize and resensitize; thus, if synaptic desensitization
were affecting the amplitudeof the test EPSC, the fluctu-
ation in T1 and T2 should have still been evident. In-
Modulation of NMDA Receptorsstead, T1 and T2 reached thesame, constant amplitude
by Norepinephrine(see Figures 2B and 2C), consistent with the idea that, in
Norepinephrine has a variety of effects at a- as well asthe presence of PKI, NMDA receptors were irreversibly
b-adrenergic receptors in the hippocampus, many ofdephosphorylated to a low Po state.
which increase excitability of pyramidal cells (reviewed
in Nicoll et al., 1990), consistent with the observationDiscussion
that stimulation of the locus coeruleus increases the
amplitude of the evoked population spike in the CA1PKA-Mediated Regulation of NMDA Receptor Po
of anesthetized rats (Olpe et al., 1986). Activation ofThese experiments provide evidence that the amplitude
b-adrenergic receptors can decrease the resting K1 con-of NMDA receptor±mediated EPSCs in hippocampal
ductance and suppresses Ca21-activated K1 currents,neurons is regulated by PKA, since cycling of the test
strongly reducing spike frequency accommodation inEPSC from high amplitude (T1) to low amplitude (T2)
CA1 cells (Madison and Nicoll, 1982, 1986a; Dunwiddiecan be blocked by inhibiting PKA with PKI. Additionally,
et al., 1992; Pedarzini and Storm, 1993). The latter actiondirectly activating adenylyl cyclase (forskolin), mimick-
can be enhanced by interactions with other G protein±ing cAMP (Sp cAMPS and Sp cBIMPS), or applying neu-
rotransmitter receptor agonists that positively couple to coupled neurotransmitters (Andrade, 1993; Gereau and
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was given, with interpulse intervals of 35, 20, and 20 ms, followedConn, 1994). In addition, b-adrenergic receptor stimula-
by a test stimulus 1.5 s later. During the conditioning stimuli, thetion increases voltage-gated Ca21 current in dentate
synapse was bathed either in control solution, in which case condi-granule cells (Gray and Johnston, 1987). While activation
tioning EPSCs were elicited, or in D-AP5 solution, in which case
of a-adrenergic receptors can depress transmission at transmitter was released but NMDA receptors were not activated.
the mossy fiber±CA3 synapse (Scanziani et al., 1993), The D-AP5 solution was applied for 200 ms and washed away well
before the test EPSC 1.5 s later. Removal of D-AP5 was monitoreda-adrenergic effects also include disinhibition of CA1
by ascertaining that test EPSCs following 6D-AP5 application inpyramidal cells, probably by presynaptic inhibition of
the absence of conditioning stimuli were of equal amplitudes; i.e.,inhibitory interneurons (Madison and Nicoll, 1988; Doze
there was no residual D-AP5 block. In this way, the test EPSCs,et al., 1991). The present experiments reveal another
called T1 and T2 for test following a conditioning train with and
means by which norepinephrine can contribute to an without D-AP5, respectively, could be compared for postsynaptic
enhancement of excitation or synaptic strength inhippo- changes while controlling for presynaptic effects of stimulation and
drugs. The relative amplitudesof T2 and thefirst conditioning EPSC,campal CA1 neurons, in this case by increasing the Po
C1, varied widely (range T2/C1 5 0.45±0.99), which probably resultsof NMDA receptors and augmenting the total Ca21 flux
partly from presynaptic depression. Nevertheless, the amount ofinto CA1 neurons during repetitive stimulation.
presynaptic depression in each cell should be comparable with or
without D-AP5, and therefore, differences between T1 and T2 are
Experimental Procedures probably postsynaptic in origin (Tong et al., 1995).
Data acquisition and analysis were accomplished with software
Preparation written in AXOBASIC. An ªepisodeº was defined as a train of condi-
Autaptic microdot cultures (Segal and Furshpan, 1990; Bekkers and tioning pulses with the following test pulse. The interval between
Stevens, 1991; Tong et al., 1995) from the CA1 region of the rat episodes was 15 s. At least 5 episodes were recorded without the
hippocampus were used 6±12 days after plating. D-AP5 application during the conditioning train, followed by 5 epi-
sodes with the D-AP5 application. This sequence was repeated 2±10
times. For measurement of the test EPSC ratio, all episodes in eitherRecording
condition (6D-AP5) were averaged while eliminating the first testRecording pipettes were pulled from 1.5 mm thin-walled borosilicate
EPSC of each set of episodes from the average; e.g., in Figure 1B,glass (WPI) to give an electrode resistance of 1±4 MV. Pipettes were
episodes 2±5, 12±15, 22±25, etc., would be averaged for T2. In thisfilled with an intracellular solution of 140 mM K±gluconate, 6.23 mM
way, the full extent of the difference between T1 and T2 could beCaCl2, 10 mM NaCl, 2 mM MgCl2, 10 mM EGTA, 10 mM HEPES, 2
measured (see Figure 5).mM K2ATP, and 0.1 mM Na2GTP (buffered to pH 7.4 with KOH),
Drugs were obtained from the following sources: CalBiochemexcept in the experiments of Figure 5A, which had 0.5 mM EGTA
(ATP, GTP, forskolin, dideoxyforskolin, Rp cAMPS, Sp cAMPS, andand no added CaCl2. Extracellular solution contained 160 mM NaCl,
PKC inhibitor peptide 19±36), Biolog (Sp cBIMPS), Sigma (picro-3 mM CaCl2, 3 mM KCl, and 5 mM HEPES (buffered to pH 7.4 with
toxin, PKI 5±24, norepinephrine, propranolol, and isoproterenol),NaOH). Recordings were made under whole-cell voltage clamp with
Tocris Cookson (D-AP5), RBI (UK14304), and Precision Neurochemi-an Axopatch 1C amplifier (Axon Instruments), and access resist-
cals (DNQX). NBQX was a kind gift from Novo Nordisk.ances were usually ,6 MV with 60%±80% compensation. Cells
were held at 270 mV. In the microdot cultures, cells form synapses
onto themselves, and synaptic currents can be evoked and recorded
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